Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01D CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES
L01DB Anthracyclines and related substances
L01DB10 Amrubicin
D07100 Amrubicin hydrochloride (JAN/USAN) <JP>
Therapeutic category of drugs in Japan [BR:br08301]
4 Agents affecting cellular function
42 Antineoplastics
423 Antibiotics
4235 Anthracycline antibiotics
D07100 Amrubicin hydrochloride (JAN/USAN)
Drug groups [BR:br08330]
Antineoplastic
DG01682 Anthracycline antineoplastic
DG00703 Amrubicin
D07100 Amrubicin hydrochloride
DG01529 Topoisomerase inhibitor
DG01527 Topoisomerase II inhibitor
DG00703 Amrubicin
D07100 Amrubicin hydrochloride
Target-based classification of drugs [BR:br08310]
Enzymes
Isomerases (EC5)
DNA topoisomerase
TOP2
D07100 Amrubicin hydrochloride (JAN/USAN) <JP>
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D07100
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D07100
Drug groups [BR:br08330]
Antineoplastic
DG01682 Anthracycline antineoplastic
DG00703 Amrubicin
DG01529 Topoisomerase inhibitor
DG01527 Topoisomerase II inhibitor
DG00703 Amrubicin